Dudediligence.

Edgewise Therapeutics, Inc

EWTXNASDAQ · Pharmaceutical Preparations
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Aug 613GPassive stake of 5% or more (13G), filed by Fmr
  2. Aug 610-QQuarterly report
  3. Aug 68-KResults of operations2.029.01
  4. Jul 168-K/AFinancial statements and exhibits (amended)9.01
  5. Jul 138-KAcquisition or sale of assets completed and Regulation FD disclosure2.017.019.01
  6. Jun 58-KShareholder vote5.07
  7. Jun 18-KMaterial agreement1.019.01
  8. May 78-KResults of operations2.029.01
  9. May 710-QQuarterly report
  10. Feb 2610-KAnnual report
  11. Feb 268-KResults of operations2.029.01
  12. Nov 20, 20258-KOfficer or director change5.029.01
  13. Nov 10, 20258-KOfficer or director change and Regulation FD disclosure5.027.019.01
  14. Nov 6, 202510-QQuarterly report
  15. Nov 6, 20258-KResults of operations2.029.01
  16. Aug 7, 202510-QQuarterly report
  17. Aug 7, 20258-KResults of operations2.029.01
  18. Jun 26, 20258-KRegulation FD disclosure and other events7.018.019.01
  19. May 8, 202510-QQuarterly report
  20. May 8, 20258-KResults of operations2.029.01
  21. Apr 2, 2025424B5Prospectus for an offering
  22. Apr 2, 20258-KMaterial agreement and Regulation FD disclosure1.017.019.01
  23. Apr 2, 20258-KRegulation FD disclosure and other events7.018.019.01
  24. Mar 3, 202510-KAnnual report
  25. Mar 3, 20258-KResults of operations2.029.01
  26. Jan 22, 20258-KOfficer or director change5.02
  27. Dec 16, 20248-KRegulation FD disclosure and other events7.018.019.01
  28. Nov 7, 202410-QQuarterly report
  29. Nov 7, 20248-KResults of operations2.029.01